ANIX
Anixa Biosciences·NASDAQ
--
--(--)
--
--(--)
ANIX fundamentals
During Q1 2026, Anixa Biosciences (ANIX) reported revenue of 0, a YoY change of 0.00%. Net income was -2.58M, a YoY change of 19.55%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q2,2016 | Q3,2016 | Q4,2016 | Q1,2017 | Q2,2017 | Q3,2017 | Q4,2017 | Q1,2018 | Q2,2018 | Q3,2018 | Q4,2018 | Q1,2019 | Q2,2019 | Q3,2019 | Q4,2019 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | Q1,2026 | TTM |
|---|
Start Date | Feb 1, 2016 | May 1, 2016 | Aug 1, 2016 | Nov 1, 2016 | Feb 1, 2017 | May 1, 2017 | Aug 1, 2017 | Nov 1, 2017 | Feb 1, 2018 | May 1, 2018 | Aug 1, 2018 | Nov 1, 2018 | Feb 1, 2019 | May 1, 2019 | Aug 1, 2019 | Nov 1, 2019 | Feb 1, 2020 | May 1, 2020 | Aug 1, 2020 | Nov 1, 2020 | Feb 1, 2021 | May 1, 2021 | Aug 1, 2021 | Nov 1, 2021 | Feb 1, 2022 | May 1, 2022 | Aug 1, 2022 | Nov 1, 2022 | Feb 1, 2023 | May 1, 2023 | Aug 1, 2023 | Nov 1, 2023 | Feb 1, 2024 | May 1, 2024 | Aug 1, 2024 | Nov 1, 2024 | Feb 1, 2025 | May 1, 2025 | Aug 1, 2025 | Nov 1, 2025 | -- |
End Date | Apr 30, 2016 | Jul 31, 2016 | Oct 31, 2016 | Jan 31, 2017 | Apr 30, 2017 | Jul 31, 2017 | Oct 31, 2017 | Jan 31, 2018 | Apr 30, 2018 | Jul 31, 2018 | Oct 31, 2018 | Jan 31, 2019 | Apr 30, 2019 | Jul 31, 2019 | Oct 31, 2019 | Jan 31, 2020 | Apr 30, 2020 | Jul 31, 2020 | Oct 31, 2020 | Jan 31, 2021 | Apr 30, 2021 | Jul 31, 2021 | Oct 31, 2021 | Jan 31, 2022 | Apr 30, 2022 | Jul 31, 2022 | Oct 31, 2022 | Jan 31, 2023 | Apr 30, 2023 | Jul 31, 2023 | Oct 31, 2023 | Jan 31, 2024 | Apr 30, 2024 | Jul 31, 2024 | Oct 31, 2024 | Jan 31, 2025 | Apr 30, 2025 | Jul 31, 2025 | Oct 31, 2025 | Jan 31, 2026 | -- |
Fiscal Year-End | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | Oct 31 | -- |
Revenue | -- -- | 100.00K +5.26% | 200.00K -- | -- -- | -- -- | 362.50K +262.50% | 0 -100.00% | -- -- | 750.00K -- | 362.50K -- | 0 -- | -- -- | 250.00K -66.67% | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | 513.00K -- | -- -- | -- -- | -1.00K -- | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | 210.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- |
Sales and Services Revenue | -- -- | 100.00K +5.26% | 200.00K -- | -- -- | -- -- | 362.50K +262.50% | 0 -100.00% | -- -- | 750.00K -- | 362.50K -- | 0 -- | -- -- | 250.00K -66.67% | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | 513.00K -- | -- -- | -- -- | -1.00K -- | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | 210.00K -- | 0 -- | 0 -- | 0 -- | 0 -100.00% | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | -- -- |
Cost of Revenue | 15.52K -87.13% | 70.27K -13.83% | 71.98K +216.37% | -- -- | -- -- | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -15.52K +83.77% | 29.73K +121.08% | 128.02K +662.64% | -- -- | -- -- | 362.50K +1119.35% | 0 -100.00% | -- -- | 750.00K -- | 362.50K -- | 0 -- | -- -- | 250.00K -66.67% | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | 513.00K -- | -- -- | -- -- | -513.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | 210.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 1.13M -44.40% | 1.00M -33.21% | 1.04M -9.83% | 1.39M -1.26% | 1.21M +6.99% | 2.09M +108.38% | 1.74M +66.87% | 1.87M +34.38% | 2.15M +77.47% | 5.97M +185.10% | 5.41M +211.20% | 4.98M +165.86% | 2.84M +32.18% | 2.18M -63.40% | 2.13M -60.64% | 2.63M -47.23% | 2.67M -6.09% | 2.44M +11.52% | 2.24M +5.34% | 2.75M +4.42% | 2.44M -8.73% | 4.39M +80.13% | 4.08M +81.78% | 3.88M +41.30% | 3.59M +47.27% | 2.80M -36.26% | 3.61M -11.46% | 2.56M -34.12% | 2.77M -22.82% | 2.84M +1.68% | 3.05M -15.46% | 3.61M +41.20% | 3.47M +25.16% | 3.59M +26.30% | 3.16M +3.67% | 3.39M -6.18% | 3.00M -13.38% | 2.44M -32.18% | 2.88M -9.07% | 2.72M -19.79% | 11.03M -- |
Selling, General and Administrative Expenses | 740.28K -63.67% | 712.55K -52.63% | 627.83K +41.60% | 941.21K -1.42% | 780.67K +5.46% | 1.59M +123.05% | 1.42M +126.93% | 1.07M +13.83% | 990.09K +26.83% | 2.79M +75.24% | 2.39M +67.79% | 2.32M +116.33% | 1.41M +42.17% | 1.10M -60.55% | 1.26M -47.40% | 1.14M -50.84% | 1.44M +2.40% | 1.18M +7.55% | 1.83M +45.89% | 1.53M +34.56% | 1.42M -1.83% | 2.22M +87.93% | 1.90M +3.73% | 2.04M +33.20% | 1.85M +31.02% | 1.35M -39.13% | 1.92M +1.10% | 1.49M -27.13% | 1.61M -13.11% | 1.76M +29.88% | 1.44M -25.36% | 2.26M +51.88% | 1.82M +13.04% | 1.67M -5.07% | 1.69M +17.48% | 1.83M -18.85% | 1.68M -7.69% | 1.38M -17.16% | 1.73M +2.79% | 1.61M -12.00% | 6.41M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 5.60M -- | -- -- | -- -- | -- -- | 7.07M +26.37% | -- -- | -- -- | -- -- | 7.17M +1.40% | -- -- | -- -- | 1.76M -- | 1.44M -79.98% | 2.26M -- | 1.82M -- | 1.67M -5.07% | 1.69M +17.48% | 1.83M -18.85% | 1.68M -7.69% | 1.38M -17.16% | 1.73M +2.79% | 1.61M -12.00% | 6.41M -- |
Research and Development Expenses | 392.59K -- | 292.06K -- | 413.49K -41.88% | 451.63K -1.40% | 431.12K +9.82% | 362.97K +24.28% | 351.83K -14.91% | 777.87K +72.24% | 660.19K +53.13% | 2.94M +710.56% | 2.43M +591.50% | 2.25M +188.90% | 1.27M +92.28% | 1.09M -63.10% | 871.19K -64.19% | 1.49M -33.67% | 1.23M -3.20% | 1.25M +15.53% | 407.70K -53.20% | 828.00K -44.45% | 1.02M -16.83% | 2.17M +72.79% | 2.17M +433.00% | 1.84M +121.98% | 1.74M +69.77% | 1.45M -33.32% | 1.69M -22.46% | 1.07M -41.89% | 998.00K -42.48% | 1.09M -24.71% | 1.61M -4.15% | 1.35M +26.31% | 1.65M +64.93% | 1.93M +76.93% | 1.48M -8.61% | 1.55M +15.05% | 1.32M -19.68% | 1.05M -45.19% | 1.14M -22.63% | 1.10M -28.99% | 4.62M -- |
Other Operating Expenses | -- -- | -- -- | -- -- | 2.12K -- | 225 -- | 141.13K -- | -38.92K -- | 25.35K +1095.33% | 500.67K +222420.00% | 241.16K +70.88% | 584.21K +1601.17% | 418.75K +1551.68% | 166.25K -66.79% | -- -- | 0 -100.00% | -- -- | -- -- | -- -- | 0 -- | 385.00K -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 161.00K -- | 0 -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -1.15M +46.17% | -974.88K +34.60% | -913.30K +22.44% | -1.39M +5.26% | -1.21M -5.54% | -1.73M -77.55% | -1.74M -90.26% | -1.87M -34.38% | -1.40M -15.59% | -5.61M -223.86% | -5.41M -211.20% | -4.98M -165.86% | -2.59M -85.10% | -2.18M +61.03% | -2.13M +60.64% | -2.63M +47.23% | -2.67M -2.97% | -2.44M -11.52% | -2.24M -5.34% | -2.23M +15.09% | -2.44M +8.73% | -4.39M -80.13% | -4.08M -81.83% | -3.88M -73.76% | -3.59M -47.27% | -2.80M +36.26% | -3.61M +11.48% | -2.56M +34.12% | -2.56M +28.67% | -2.84M -1.68% | -3.05M +15.46% | -3.61M -41.20% | -3.47M -35.43% | -3.59M -26.30% | -3.16M -3.67% | -3.39M +6.18% | -3.00M +13.38% | -2.44M +32.18% | -2.88M +9.07% | -2.72M +19.79% | -11.03M -- |
Non-Operating Income (Loss) | -123.51K -19.41% | -128.89K -15.64% | -134.37K -16.96% | -194.30K -61.04% | 1.37M +1211.28% | -63.48K +50.75% | -48.14K +64.17% | 9.11K +104.69% | 8.44K -99.39% | 12.23K +119.26% | 16.19K +133.64% | 17.12K +87.87% | 18.30K +116.82% | 18.36K +50.18% | 17.57K +8.50% | 13.29K -22.34% | 12.15K -33.62% | -140.82K -866.82% | 1.22K -93.08% | 1.00K -92.48% | -- -- | -- -- | 6.00K +393.42% | 1.00K -- | 1.00K -- | 22.00K -- | 80.00K +1233.33% | 202.00K +20100.00% | 253.00K +25200.00% | 296.00K +1245.45% | 330.00K +312.50% | 319.00K +57.92% | 287.00K +13.44% | 277.00K -6.42% | 250.00K -24.24% | 173.00K -45.77% | 190.00K -33.80% | 156.00K -43.68% | 154.00K -38.40% | 131.00K -24.28% | 631.00K -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | 1.55M -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -148.08K -- | 0 -- | -- -- | -- -- | -- -- | 6.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Interest Expense | 123.51K +19.41% | 128.89K +15.64% | 134.37K +16.96% | 194.30K +61.04% | 175.10K +41.77% | 63.48K -50.75% | 48.14K -64.17% | -9.11K -104.69% | -8.44K -104.82% | -12.23K -119.26% | -16.19K -133.64% | -17.12K -87.87% | -18.30K -116.82% | -18.36K -50.18% | -17.57K -8.50% | -13.29K +22.34% | -12.15K +33.62% | -7.27K +60.43% | -1.22K +93.08% | -1.00K +92.48% | -- -- | -- -- | 0 +100.00% | -1.00K -- | -1.00K -- | -22.00K -- | -80.00K -- | -202.00K -20100.00% | -253.00K -25200.00% | -296.00K -1245.45% | -330.00K -312.50% | -319.00K -57.92% | -287.00K -13.44% | -277.00K +6.42% | -250.00K +24.24% | -173.00K +45.77% | -190.00K +33.80% | -156.00K +43.68% | -154.00K +38.40% | -131.00K +24.28% | -631.00K -- |
Interest Expense | 126.98K +16.91% | 132.36K +14.12% | 136.71K +15.73% | 195.30K +57.63% | 175.73K +38.39% | 71.67K -45.85% | 57.76K -57.75% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Income | 3.47K -32.94% | 3.47K -23.37% | 2.34K -27.84% | 999 -69.27% | 626 -81.98% | 8.19K +136.35% | 9.62K +311.24% | 9.11K +812.11% | 8.44K +1248.24% | 12.23K +49.27% | 16.19K +68.28% | 17.12K +87.87% | 18.30K +116.82% | 18.36K +50.18% | 17.57K +8.50% | 13.29K -22.34% | 12.15K -33.62% | 7.27K -60.43% | 1.22K -93.08% | 1.00K -92.48% | -- -- | -- -- | 0 -100.00% | 1.00K -- | 1.00K -- | 22.00K -- | 80.00K -- | 202.00K +20100.00% | 253.00K +25200.00% | 296.00K +1245.45% | 330.00K +312.50% | 319.00K +57.92% | 287.00K +13.44% | 277.00K -6.42% | 250.00K -24.24% | 173.00K -45.77% | 190.00K -33.80% | 156.00K -43.68% | 154.00K -38.40% | 131.00K -24.28% | 631.00K -- |
Pretax Income From Continuing Operations | -1.27M +43.13% | -1.10M +31.11% | -1.05M +18.94% | -1.59M +0.24% | 160.49K +112.62% | -1.79M -62.57% | -1.79M -70.46% | -1.87M -17.38% | -1.39M -967.67% | -5.59M -211.72% | -5.39M -201.91% | -4.97M -166.24% | -2.57M -84.91% | -2.17M +61.28% | -2.11M +60.84% | -2.62M +47.32% | -2.66M -3.23% | -2.58M -18.96% | -2.24M -6.16% | -2.23M +14.70% | -2.44M +8.31% | -4.39M -70.29% | -4.07M -81.66% | -3.88M -73.79% | -3.59M -47.23% | -2.77M +36.76% | -3.53M +13.31% | -2.35M +39.31% | -2.31M +35.70% | -2.55M +8.18% | -2.72M +22.90% | -3.29M -39.76% | -3.18M -37.84% | -3.31M -30.10% | -2.91M -7.06% | -3.21M +2.34% | -2.81M +11.54% | -2.28M +31.22% | -2.72M +6.56% | -2.58M +19.55% | -10.40M -- |
Income Tax Expense | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -1.27M +43.13% | -1.10M +31.11% | -1.05M +18.94% | -1.59M +0.24% | 160.49K +112.62% | -1.79M -62.57% | -1.79M -70.46% | -1.87M -17.38% | -1.39M -967.67% | -5.59M -211.72% | -5.39M -201.91% | -4.97M -166.24% | -2.57M -84.91% | -2.17M +61.28% | -2.11M +60.84% | -2.62M +47.32% | -2.66M -3.23% | -2.58M -18.96% | -2.24M -6.16% | -2.23M +14.70% | -2.44M +8.31% | -4.39M -70.29% | -4.07M -81.66% | -3.88M -73.79% | -3.59M -47.23% | -2.77M +36.76% | -3.53M +13.31% | -2.35M +39.31% | -2.31M +35.70% | -2.55M +8.18% | -2.72M +22.90% | -3.29M -39.76% | -3.18M -37.84% | -3.31M -30.10% | -2.91M -7.06% | -3.21M +2.34% | -2.81M +11.54% | -2.28M +31.22% | -2.72M +6.56% | -2.58M +19.55% | -10.40M -- |
Net Income Attributable to Minority Interests | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -27.40K -- | -13.98K -- | -116.65K -- | -89.03K -- | -84.77K -209.35% | -37.24K -166.39% | -26.02K +77.69% | -23.57K +73.53% | -24.03K +71.65% | -17.90K +51.94% | -15.10K +41.96% | -16.98K +27.97% | -24.00K +0.13% | -38.00K -112.33% | -54.00K -257.54% | -58.00K -241.66% | -50.00K -108.33% | -44.00K -15.79% | -29.00K +46.30% | -53.00K +8.62% | -32.00K +36.00% | -19.00K +56.82% | -37.00K -27.59% | -31.00K +41.51% | -35.00K -9.38% | -41.00K -115.79% | -38.00K -2.70% | -30.00K +3.23% | -29.00K +17.14% | -23.00K +43.90% | -22.00K +42.11% | -27.00K +10.00% | -20.00K +31.03% | -92.00K -- |
Net Income Attributable to Owners of the Company | -1.27M +43.13% | -1.10M +31.11% | -1.05M +18.94% | -1.59M +0.24% | 160.49K +112.62% | -1.79M -62.57% | -1.79M -70.46% | -1.84M -15.66% | -1.38M -958.96% | -5.48M -205.22% | -5.30M -196.92% | -4.88M -165.60% | -2.54M -84.09% | -2.14M +60.93% | -2.09M +60.63% | -2.59M +46.89% | -2.64M -4.04% | -2.56M -19.70% | -2.22M -6.54% | -2.21M +14.83% | -2.40M +9.13% | -4.33M -69.19% | -4.01M -80.44% | -3.83M -73.41% | -3.54M -47.73% | -2.75M +36.64% | -3.48M +13.38% | -2.32M +39.36% | -2.29M +35.44% | -2.51M +8.56% | -2.69M +22.61% | -3.25M -40.18% | -3.14M -37.19% | -3.28M -30.51% | -2.88M -7.17% | -3.18M +2.18% | -2.79M +11.12% | -2.26M +31.10% | -2.69M +6.52% | -2.56M +19.44% | -10.31M -- |
Preferred Stock Dividends | -- -- | -- -- | -- -- | 2.01M -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -1.27M +43.13% | -1.10M +31.11% | -1.05M +18.94% | -3.60M -125.85% | 160.49K +112.62% | -1.79M -62.57% | -1.79M -70.46% | -1.84M +48.91% | -1.38M -958.96% | -5.48M -205.22% | -5.30M -196.92% | -4.88M -165.60% | -2.54M -84.09% | -2.14M +60.93% | -2.09M +60.63% | -2.59M +46.89% | -2.64M -4.04% | -2.56M -19.70% | -2.22M -6.54% | -2.21M +14.83% | -2.40M +9.13% | -4.33M -69.19% | -4.01M -80.44% | -3.83M -73.41% | -3.54M -47.73% | -2.75M +36.64% | -3.48M +13.38% | -2.32M +39.36% | -2.29M +35.44% | -2.51M +8.56% | -2.69M +22.61% | -3.25M -40.18% | -3.14M -37.19% | -3.28M -30.51% | -2.88M -7.17% | -3.18M +2.18% | -2.79M +11.12% | -2.26M +31.10% | -2.69M +6.52% | -2.56M +19.44% | -10.31M -- |
Other Comprehensive Income | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -10.09M -- | -- -- | -- -- | -- -- | -13.13M -30.08% | -- -- | -- -- | -- -- | -13.77M -4.90% | -- -- | -- -- | -2.55M -- | -2.72M +80.24% | -3.29M -- | -3.18M -- | -3.31M -30.10% | -2.91M -7.06% | -3.21M +2.34% | -2.81M +11.54% | -2.28M +31.22% | -2.72M +6.56% | -2.58M +19.55% | -10.40M -- |
Basic EPS | -0.15 +42.31% | -0.13 +27.78% | -- -- | -0.41 -127.78% | 0.02 +113.33% | -0.12 +7.69% | -0.11 -- | -0.11 +73.17% | -0.08 -500.00% | -0.3 -150.00% | -0.28 -154.55% | -0.25 -127.27% | -0.13 -62.50% | -0.11 +63.33% | -0.1 +64.29% | -0.13 +48.00% | -0.12 +7.69% | -0.11 -- | -0.09 +10.00% | -0.09 +30.77% | -0.08 +33.33% | -0.14 -27.27% | -0.13 -44.44% | -0.13 -44.44% | -0.12 -50.00% | -0.09 +35.71% | -0.11 +15.38% | -0.08 +38.46% | -0.07 +41.67% | -0.08 +11.11% | -0.09 +18.18% | -0.1 -25.00% | -0.1 -42.86% | -0.1 -25.00% | -0.09 -- | -0.1 -- | -0.09 +10.00% | -0.07 +30.00% | -0.08 +11.11% | -0.08 +20.00% | -0.32 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.08 -- | -- -- | -0.1 -- | -0.1 -- | -0.1 -25.00% | -- -- | -0.1 -- | -0.09 +10.00% | -0.07 +30.00% | -- -- | -0.08 +20.00% | -- -- |
Diluted EPS | -0.15 +42.31% | -0.13 +27.78% | -- -- | -0.41 -127.78% | 0.02 +113.33% | -0.12 +7.69% | -- -- | -0.11 +73.17% | -0.08 -500.00% | -0.3 -150.00% | -- -- | -0.25 -127.27% | -0.13 -62.50% | -0.11 +63.33% | -- -- | -0.13 +48.00% | -0.12 +7.69% | -0.11 -- | -- -- | -0.09 +30.77% | -0.08 +33.33% | -0.14 -27.27% | -- -- | -0.13 -44.44% | -0.12 -50.00% | -0.09 +35.71% | -- -- | -0.08 +38.46% | -0.07 +41.67% | -0.08 +11.11% | -- -- | -0.1 -25.00% | -0.1 -42.86% | -0.1 -25.00% | -- -- | -0.1 -- | -0.09 +10.00% | -0.07 +30.00% | -- -- | -0.08 +20.00% | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -0.08 -- | -- -- | -0.1 -- | -0.1 -- | -0.1 -25.00% | -- -- | -0.1 -- | -0.09 +10.00% | -0.07 +30.00% | -- -- | -0.08 +20.00% | -- -- |
You can ask Aime
Did Anixa Biosciences beat or miss consensus estimates last quarter?What were the key takeaways from Anixa Biosciences's earnings call?What guidance did Anixa Biosciences's management provide for the next earnings period?What does Anixa Biosciences do and what are its main business segments?What is Anixa Biosciences's latest dividend and current dividend yield?What is Anixa Biosciences's gross profit margin?What is the market's earnings forecast for Anixa Biosciences next quarter?What were the key takeaways from Anixa Biosciences’s earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
